L26/P-726 Targeted lipidomics in serum for risk prediction of premature ovarian insufficiency
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Q. Zhu und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can the serum lipidomics serve as potential predictive markers for premature ovarian insufficiency (POI)? What are the roles and mechanisms of key lipid metabolic markers? Summary answer Multiple serum lipid metabolites in patients can serve as predictive markers, and changes in their metabolic levels effectively indicate the risk of POI. What is known already POI poses a major threat to female reproductive health, with its pathogenesis closely linked to endocrine disorders and oxidative stress. Lipid metabolism is involved in regulating the homeostasis of the reproductive system; existing studies suggest that abnormal lipid profiles may be associated with ovarian dysfunction, but research on predicting this condition via targeted serum lipid metabolome remains limited. Study design, size, duration A case-control study was conducted, enrolling 71 patients with POI and 55 healthy controls (in two batches, with more samples planned). Serum samples were collected for targeted lipid metabolome detection to analyze differential metabolites and establish a prediction model, with a study duration of 10 months. Participants/materials, setting, methods Study subjects were reproductive-aged women meeting diagnostic criteria. Targeted lipidomics detected serum lipid components, and bioinformatics analysis screened differential metabolites. Machine learning (LASSO regression/random forest) was applied to construct a POI. Main results and the role of chance A total of 67 differential lipid metabolites were identified, among which phospholipids and triglycerides showed the most significant differences. The prediction model constructed with 10 core metabolites had an AUC of 0.82, with both sensitivity and specificity exceeding 80%. Experimental data were validated twice, demonstrating good repeatability; random errors had little impact on the results, and the expression levels of core metabolites were significantly correlated with ovarian function indices. Limitations, reasons for caution This is a single-center study with a limited sample size, lacking refined analysis across different age strata. Future studies need to expand the sample size and conduct multi-center research to verify the stability of the results. Wider implications of the findings It provides a non-invasive and efficient predictive method for POI, facilitating early screening and intervention, and offers a new direction for exploring the mechanism by which lipid metabolism regulates ovarian function. Trial registration number No
Zitieren
APA
Zhu, Q., Sun, L., Huang, G., & Li, J. (2026). L26/P-726 Targeted lipidomics in serum for risk prediction of premature ovarian insufficiency. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1053
Vancouver
Zhu Q, Sun L, Huang G, Li J. L26/P-726 Targeted lipidomics in serum for risk prediction of premature ovarian insufficiency. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1053
BibTeX
@article{Zhu2026,
author = {Zhu, Q. and Sun, L. and Huang, G. and Li, J.},
title = {L26/P-726 Targeted lipidomics in serum for risk prediction of premature ovarian insufficiency},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1053}
}
EUVIMED